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ABSTRACT
Prevalence of diabetes is increasing in pandemic
proportions, particularly in developing countries like
India. The recent reports from the World Health
Organization rates India as the country with the
largest number of diabetic subjects in the world. The
Chennai Urban Population Study (CUPS), The
Chennai Urban Rural Epidemiology Study (CURES)
and the National Urban Diabetes Survey (NUDS)
revealed rising prevalence of diabetes in India. Some
of the significant risk factors associated with
diabetes are similar worldwide, but their intensities
vary between races, regions and countries. The
reason for escalation of diabetes prevalence in India
could be attributed to a combination of genetic
factors and environmental factors due to urbanization
and industrialization, which has led to sedentary
lifestyle, physical inactivity, stress and obesity
arising from energy and fat rich diets. The long-term
complications of diabetes occurring during the most
productive years of their lives create a devastating
burden of morbidity and mortality, which poses an
economic and social burden both at the individual
and at the national level. Compared to non-diabetic
individuals, diabetic individuals are more than twice
as costly to treat, mainly due to the high costs
re lated wi th management of  associated
complications. Prevention seems to be the need of
the hour to tackle this epidemic. This article highlights
the social and economic implications of diabetes in
India and emphasis the measures required to prevent
diabetes.
KEY WORDS: Indians; Diabetes; CURES; CUPS;
Health economics.
INTRODUCTION
As we enter the new millennium, diabetes mellitus
has become a problem of epidemic proportions. It
touches us in every walk of life – physician and
scientist, family and friend, even governments and
communities – and it exacts a costly toll.
Diabetes mellitus is defined by the American
Diabetes Association (ADA) Expert Committee in their
1997 recommendations as “a group of metabolic
diseases characterized by hyperglycemia resulting
from defects in insulin secretion, insulin action or
both. The chronic hyperglycemia is associated with
long-term damage, dysfunction and failure of various
organs, especially the eyes, kidney, nerves, heart and
blood vessels.” Thus, diabetes covers a wide range
of heterogeneous diseases (1).
Type 2 diabetes is by far the commonest form of
the disease globally with rapidly developing countries
being at the forefront of this epidemic. Current
estimates – almost certainly conservative - are that
at least 150 million people worldwide have diabetes,
of which two-thirds live in developing countries (2).
The total number of people with diabetes is predicted
to rise to about 300 million by 2025, with one-third of
affected individuals living in India and China alone.
The largest increases in the diabetic population in
developing countries are projected to be in the most
economically productive age groups (3).
DIABETES – INDIAN SCENARIO
India with its dubious distinction of being called,
“the diabetic capital of the world” is presently estimated
to have over 30 million individuals affected by this
deadly disease. India is ahead of China and USA,
which are in second and third place respectively.
Figure 1 depicts the projected number of people with
diabetes among adults in India in the years 1995,
2003 and 2030. This represents a three hundred
percent increase in the number of people with diabetes
between 1995 and 2030 (3). A striking example of
the rise in prevalence of diabetes in India is the fivefold
increase from 2.1% to 12.1% seen from 1970 to 2000
(4-9). Two population based studies, the Chennai
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Urban Population Study (CUPS) and Chennai Urban
Rural Epidemiological Study (CURES) showed a
marked increase in the prevalence of diabetes within
a short span of f ive years. The CUPS study
conducted in the year 1997 revealed that 12% (crude
prevalence rate) of the Chennai population to be
affected by diabetes (5, 6). The National Urban
Diabetes Survey (NUDS), carried out in six cities in
the year 2001, reported the age-standardized
prevalence rates of 12% for diabetes for urban India
(9). The age-standardized prevalence of diabetes in
Chennai according to this study was 13.5 %. In
addition the study also reported that 14% had impaired
glucose tolerance (IGT). The city of Hyderabad
showed the highest rates of both diabetes (17%) and
IGT (30%). In Chennai, Bangalore, Hyderabad and
Mumbai, the prevalence of IGT exceeded those of
diabetes (9). The large population based study,
CURES conducted on 26,001 individuals in the year
2001- 2002, showed that according to the ADA criteria
19% had diabetes in Chennai and this scaled down
to 16% when WHO criteria was used (10).  This
modification was based on an extrapolation of the
results of oral glucose tolerance test on a sub-sample
population (n=2000). Figure 2 shows the progressive
rise in estimated prevalence of diabetes in urban India
based on the available data (5).
Interesting differences are observed in the age-wise
distribution of the diabetic population in the developed
and developing countries. While in the developed
world, the majority of diabetics are aged 65 years
and above, in the developing world, the majority of
diabetics are in the age group of 45-64 years.
According to the CUPS study the prevalence of
diabetes between the ages of 45 to 60 years was
nearly 25%, which was similar to that seen among
individuals above the age of 65 years in developing
countries (8). Figure 3 compares the age of newly
diagnosed subjects in the CUPS study. These data
have a lot of significance since diabetes sets in during
the most productive period of their lives (8). This in
turn, has major implications with respect to health
care needs.
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Figure 3: Age at Onset of Diabetes in Indians–the Data
are Obtained from the newly Diagnosed Subjects from
CUPS and the Numbers Refer to Percentage of Diabetic
Subjects
URBANIZATION AND DIABETES
The rapid epidemiological transition occurring in
India with increased urbanization and westernization,
have already contributed to a substantial rise in
diabetes. The current urbanization rate is 35%
compared to 15% in the 1950’s and this could have
major implications on the present and future disease
patterns in India with particular reference to diabetes
and coronary artery disease (3, 11). All over the world,
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Figure 1: Estimated Number of People with
Diabetes in India, 1995 to 2030.
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traditional lifestyles and dietary patterns that have
sustained people over generations are disappearing.
Socio-economic development over the last 40-50
years in India has resulted in a dramatic change in
lifestyle from traditional to modern, leading to physical
inactivity due to technological advancement, affluence
leading to consumption of diets rich in fat, sugar and
calories and a high level of mental stress. All these
could adversely influence insulin sensitivity and lead
to obesity. This is reflected from results of prevalence
studies conducted in southern and northern parts of
India comparing urban and rural populations, showing
the prevalence to be 2.4% in rural population as
compared to 11.6% in urban population in south India
(7, 8, 12, 13) while in north India (Moradabad) the
prevalence of diabetes was 2.8% vs. 6.0 %
respectively in rural and urban areas (14).
In developing countries, the prevalence of diabetes
is lower among those with a low income than among
more affluent groups (6, 15, 16). The impact of
urbanization on the prevalence of diabetes in India is
clearly shown in the CUPS study. The higher socio-
economic status (SES) group had two-fold higher
prevalence of diabetes compared to the lower socio-
economic group (6). The reason for high prevalence
has been attributed to the consumption of unhealthy
diet like foods rich in calorie and fat and lack of physical
activity in the higher SES group. The same study also
demonstrated that the prevalence of components of
the insulin resistance syndrome, which includes
diabetes, hypertension, dyslipidemia and obesity are
more common among the higher SES, compared to
lower SES (6, 17, 18). The higher prevalence of
diabetes mellitus in the urban strata of Indian society
adds on to the serious implications on the economy of
our country. . It is also shown that SES also plays a
significant role in diagnosis of diabetes. In Bangalore
Urban district Diabetes (BUD) Study a four-year delay
in diagnosis of diabetes was observed between the
highest and lowest SES groups (19).
In a study conducted in Bangladesh (15), the age-
adjusted prevalence of type 2 diabetes was higher in
urban (7.97%) compared to rural population (3.84%).
Adoption of western lifestyles has lead to increasing
prevalence of type 2 diabetes and obesity in urban
compared to rural African communities (16).
In a population-based study conducted with the
aim of studying the anthropometric and metabolic
characteristics among the rural-urban migrants settled
in urban slums in North India (socio-economic
transition), the overall diabetes prevalence was 10.3%
(20). It was also observed that the prevalence of
diabetes mellitus, obesity, dyslipidemia, generalized
and regional obesity was found to be high particularly
in females. This study clearly states the need for
immediate attention in terms of prevention and health
education in economically deprived populations in
urban settings.
In the developed countries, most studies suggest
that higher prevalence of type 2 diabetes, associated
risk factors and diabetic complication rates vary
inversely with socio-economic status i.e., in the lower
SES population (21, 22).  The reason for the higher
prevalence of type 2 diabetes among subjects with
lower socio-economic status could be unhealthy life
style (23), nutritional inadequacies and psychological
stress (24). An increased rate of obesity, smoking
and physical inactivity was observed by Malmstrom
et al (25) in socially deprived areas.
It has been demonstrated that risk factors for
cardio-vascular diseases particularly smoking are
more common among people with diabetes with lower
SES in population and clinic-based studies in the
developed countries (26, 27, 28) and individuals
belonging to lower SES have an increased incidence
of retinopathy and nephropathy (26, 27). In a study
conducted in southern India (29) similar observation
was reported, that diabetic subjects from a lower SES
have a higher prevalence of cardiac disease,
neuropathy and cataract but a lower prevalence of
retinopathy compared to those from a higher SES
and the risk variables including hyperglycemia,
dyslipidemia, hypertension, smoking and alcohol
consumption were more in the low SES group. This
study suggests that while the prevalence of diabetes
is higher among the urban higher SES group, higher
rates of complications of diabetes are observed in
the lower SES group in the developing countries.
In UK, higher morbidity and mortality in diabetic
subjects has also been associated with SES (37,30),
but in a Finnish study no such correlation was found
(31) and concluded that education for diabetic people
appeared to be effective in all socio-economic strata.
Disparities in health by SES among people with
diabetes could reflect the direct effects of deprivation
on health or could result indirectly from the effects of
unfavorable health behaviors linked to lower SES.
Another potential reason could be the ‘inverse care
law’ whereby access to and use of services is
reduced, and the quality of care provided is
substandard, for patients with the greatest need (32).
ECONOMIC IMPLICATIONS
Diabetes imposes a considerable burden on health
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systems and societies. The cost implications of
diabetes to society are multifold: direct costs to
people with diabetes, their families and to the health
care sectors, indirect costs to society and
government, which are the productivity costs; and
intangible costs, which means adverse effects on
quality of life (Table 1).  Very little is known about the
economic impact of diabetes in the developing world
where predicted increases in prevalence are highest.
Diabetic individuals compared to non diabetic
individuals are more than twice as costly to treat (33),
mainly due to the high costs related with management
of diabetes associated complications (33, 34) and the
economic loss due to lost man-days or lost economic
opportunity (34). Thus diabetes affecting the earning
or active member of the family, affects not only that
individual but might often have significant effect on
the family.
Table 1: Costs of Diabetes
Direct Costs Indirect Intangible
 Costs Costs
Medical Non medical
Consultation Transportation Man days lost Reduced life
expectancy
Investigation Time utilized Low Pain and
for care productivity discomfort
Medication Disability Stress
payment
Management Social security Anxiety
Hospitalization Depression
Treating Insecurity
Complications
Inconvenience
Health Lower quality
programs of life
The economic burden of diabetes is increasing as
the epidemic grows. As per WHO estimates, diabetes
drains a significant percent of the health budget by
cost towards direct diabetes care and diabetes related
disabilities. Diabetes associated complications
account for 60% of diabetes related direct health care
costs and almost 80-90% of indirect costs (35). In
Australia, at least US$ 720 million was spent on
diabetes health care in 1995. It is projected that by
2010, costs will have risen by a further 50%. In New
Zealand, 5% of the health budget is spent on direct
diabetes care and a further 5% on diabetes related
disability allowances. In Japan, the annual direct cost
to the health care sector of diabetes is about US$
16.94 billion (6% of the total health budget in 1998).
In China, the estimated direct cost of care for people
with diabetes in 1996 was US$ 3.5 billion (36). In
South Asia, the direct cost of diabetes management
is US$ 5 billion, while indirect costs total US$ 10
billion.
In India, the per capita expenditure on health care
is only 6.4% of the average world spending, while
India accounts for 23.5% of the world’s disability
adjusted life years lost due to diabetes (DALYs) (37).
There is a paucity of information on the economic
costs of diabetes in the subcontinent. According to
our estimates, India presently has an annual
estimated treatment cost of Rs 10,000 to 12,000 crore
which is likely to witness a scaling upto as much as
Rs 1,26,000 crore by 2025 (Mohan et al, unpublished
observations). This figure includes direct costs (cost
of routine treatment, monitoring and laboratory and
hospital costs), indirect cost (cost arising from
absenteeism, lowered productivity and disability
benefits) and cost for treating diabetic complications
using conservative estimates.
Recently few studies (38, 39, 40) have been
published on the costs and sociological factors that
contribute to diabetes care in India. In the Bangalore
Urban district Diabetes (BUD) Study (38) it was
estimated that, in 1998 the annual direct cost for
routine care in Bangalore was about 191 US dollars;
the mean direct cost per hospitalization for a diabetes-
related event was about 208 US dollars. The Cost of
Diabetes in India (CODI) study (39) revealed that the
mean direct annual cost for outpatient care for
diabetes individuals was Rs. 4724/- and the total
indirect cost for non-earning diabetic patients was
estimated to be Rs. 9748/- while for earning members
it was Rs. 16831/-. When comparing the cost per
hospitalization in the BUD and CODI studies, it was
estimated to be Rs.9944/- vs Rs.10688/- respectively.
In the CODI study those without complications had
an 18% lower cost while those with three or more
complications had a 48% higher cost.
A study conducted in families having type 1
diabetes in Chennai (41) reported that a median figure
of Rs. 13,980 (US$ 310) was spent annually for
diabetes by the families and the median percentage
of annual income spent on diabetes treatment was
22% for the entire group (59% - low SES group, 32%
- middle SES group, 18% - upper middle income group
and 12% - high-income group). Another study
conducted in type 2 diabetes in Chennai, revealed
that diabetic individuals spent Rs. 4510 (US$ 100
approximately) (40).
The above estimates highlight the large differences
in diabetes care expenditure between developing and
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developed countries. From the meager data available
regarding the economic cost of diabetes, it is clear
that diabetes in the future will pose a severe burden
on the under resourced health care system in India.
Therefore action taken in early days of diabetes is
more beneficial in terms of high quality of life and is
more cost effective, especially if it can prevent
hospitalization. Proper management/prevention
requires increased awareness and education and
investment for better diabetes care.
AWARENESS AND PREVENTION
Despite several advances in the f ield of
diabetology, it is unfortunate that there exists a low
awareness of the disease among public. This explains
the findings of a recent study, which has shown that
for every one person known to have diabetes, there
are more than two people who have undiagnosed
diabetes. This means that a substantial proportion of
people with diabetes may already have developed at
least one diabetic complication by the time they are
diagnosed.
Diabetes awareness is an integral and essential
part of diabetes care for both health professionals and
diabetic individuals. Pre-diagnosis diabetes
awareness may result in earlier diagnosis of the
disorder, which has been demonstrated in various
Indian studies (38, 39). BUDS has reported that the
mean age at diagnosis was 48.3 years for those
individuals who were aware of diabetes as a disorder
compared to 50.1 years for those not aware and 47.7
years for those with a family history compared to 50.5
years for those without (38). In the CODI study 61%
of patients’ were aware of diabetes before diagnosis
(39). Twice as many patients who were aware of
diabetes and its consequences were free of
complications when compared to those who were not
aware and had similar diabetes duration (19).
Early detection and appropriate treatment are the
cornerstones for delaying the onset and progression
of the diabetic complications viz. retinopathy,
nephropathy, neuropathy, stroke, peripheral vascular
disease and ischemic heart disease. Meta-analyses
and reviews of the diabetes literature have shown that
diabetes education, awareness and improving
motivation for self care improves care, reduces
complications and may thus reduce overall economic
costs of diabetes (42, 43). It has been demonstrated
that in type-1 diabetes, early detection of nephropathy
by screening for micro albuminuria and immediate
recourse to improved control with anti-hypertensive
medications, not only increases life expectancy
significantly but also concomitantly reduces total
health care costs (44).  An intensive education
program can improve the foot care knowledge and
behavior of high-risk patients (45, 46).
Recent research advances in the etiology of
diabetes mellitus have increased our knowledge to
such an extent that both primary and secondary
prevention of diabetes mellitus has now become a
reality. Such prevention strategies should be the goal
of targeting this disease, particularly in populations
such as ours where the prevalence of diabetes is
known to have increased dramatically over recent
years. Primary prevention is aimed at reducing the
risk of the onset of diabetes mellitus while secondary
prevention includes all measures designed to reduce
the morbidity and mortality in patients with chronic
diabetes mellitus. ‘The Cost of Diabetes in Europe -
Type II (CODE-2) study’ concluded that as diabetic
complications have a substantial impact on the costs
of managing type 2 diabetes, prevention of
complications will not only benefit patients, but
potentially reduce overall healthcare expenditure (47).
Therefore, the need of the hour is prevention of this
disease by early detection and modifications in
lifestyle with the incorporation of a healthy diet, an
increase in physical activity and weight reduction for
those who are in the prediabetic stage (48) and
appropriate treatment by oral hypoglycemic agents
and insulin therapy for diabetic individuals.
Economics, it has been said, is not all about
money alone but also about humanitar ian
considerations of the quality of life of millions affected
with this dreaded disease. As healthcare
professionals, for the service of humanity and the
nation as a whole, let us all work towards managing
diabetes to minimize long-term effects and maximize
current good health and vitality.
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